| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1053/CTRV.2000.0194 |
| P698 | PubMed publication ID | 11139374 |
| P2093 | author name string | de Vries EG | |
| van der Graaf WT | |||
| Hendrikse NH | |||
| Vaalburg W | |||
| Groen HJ | |||
| Bart J | |||
| P433 | issue | 6 | |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 449-462 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Cancer Treatment Reviews | Q1955762 |
| P1476 | title | The blood-brain barrier and oncology: new insights into function and modulation | |
| P478 | volume | 26 |
| Q44540668 | Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain |
| Q34727714 | An oncological view on the blood-testis barrier. |
| Q34398602 | Basic principles of immunological surveillance of the normal central nervous system |
| Q46046498 | Biocompatibility study of glycofurol in rat brains |
| Q35082117 | Biodegradable nanoparticles for drug and gene delivery to cells and tissue |
| Q50778486 | Blood-brain barrier P-glycoprotein function in Alzheimer's disease. |
| Q36353785 | Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene |
| Q33985133 | Blood-brain barrier active efflux transporters: ATP-binding cassette gene family |
| Q38084825 | Brain metastases from colorectal cancer: microenvironment and molecular mechanisms |
| Q34455205 | Breast cancer metastasis to the central nervous system |
| Q37902641 | Cabazitaxel: a novel microtubule inhibitor |
| Q39443939 | Corrupting the DNA damage response: a critical role for Rad52 in tumor cell survival |
| Q52579808 | Current Challenges and Opportunities in Treating Glioblastoma. |
| Q37694794 | Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma |
| Q37217013 | Dietary blueberry supplementation affects growth but not vascularization of neural transplants. |
| Q39005365 | Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease. |
| Q33988704 | Drug resistance in brain diseases and the role of drug efflux transporters. |
| Q39083216 | Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells |
| Q37004561 | Evaluating Changes to Blood-Brain Barrier Integrity in Brain Metastasis over Time and after Radiation Treatment |
| Q36562978 | Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model |
| Q33684017 | Expression and clinical significance of multidrug resistance proteins in brain tumors |
| Q48543194 | Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes |
| Q48761116 | Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. |
| Q33724251 | Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. |
| Q48857140 | Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors |
| Q36851190 | Gliadel for brain metastasis. |
| Q36898699 | Glioma stem cells and immunotherapy for the treatment of malignant gliomas |
| Q36772230 | Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis |
| Q48488145 | Human brain tumor imaging with a protein-binding MR contrast agent: initial experience. |
| Q36673924 | Immunopathology of flavivirus infections |
| Q48315745 | In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts |
| Q35623290 | Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. |
| Q49137075 | Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats |
| Q41945670 | Irradiation of rat brain reduces P-glycoprotein expression and function. |
| Q30320568 | Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: relevance for their permeation across the blood-brain barrier? |
| Q39539298 | Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples |
| Q35173837 | Mechanisms of anticancer drug resistance |
| Q37313443 | Mechanisms of the penetration of blood-borne substances into the brain |
| Q35088011 | Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS. |
| Q37422646 | New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. |
| Q36170367 | No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds |
| Q30380561 | Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. |
| Q43947964 | Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography |
| Q99612681 | Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors |
| Q36382013 | P-glycoprotein function at the blood-brain barrier: effects of age and gender |
| Q35205460 | Pain and the blood-brain barrier: obstacles to drug delivery |
| Q33984222 | Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis |
| Q37353276 | Pharmacotherapy for adults with tumors of the central nervous system |
| Q36136731 | Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. |
| Q48768848 | Preparation and biocompatibility study of in situ forming polymer implants in rat brains |
| Q44671680 | Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET. |
| Q33697504 | Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice |
| Q34285753 | Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients |
| Q35742284 | Reproducibility of quantitative (R)-[11C]verapamil studies |
| Q36418108 | Role of ABC transporters in the pathogenesis of Alzheimer's disease |
| Q41668226 | Role of IFN-γ and LPS on neuron/glial co-cultures infected by Neospora caninum |
| Q36744474 | Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis |
| Q48277285 | Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. |
| Q38598523 | Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. |
| Q34974827 | Targeting the neurovascular unit for treatment of neurological disorders |
| Q55462976 | Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells. |
| Q38860029 | Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier |
| Q35817004 | The MDR1 (ABCB1) gene polymorphism and its clinical implications |
| Q41243197 | The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment |
| Q58104608 | The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes |
| Q37078957 | The emerging role of anti-angiogenic therapy for malignant glioma |
| Q34156828 | The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans |
| Q44249808 | Therapeutic links between Alzheimer's disease and brain cancer: drug discovery consequences |
| Q51533087 | Tissue Distribution and Elimination of [14C]Apixaban in Rats |
| Q27690256 | Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? |
| Q55287222 | Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. |
| Q48925865 | Vascular endothelium and the blood-brain barrier |
| Q35103013 | Vascular gene expression in nonneoplastic and malignant brain. |
| Q39793584 | Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks |
Search more.